SAHPRA recalls two batches of Benylin Paediatric Syrup.

Loading player...
GUEST Deon Poovan, SAHPRA Senior Manager: Inspectorate and Regulatory Compliance.

Two batches of Benylin cough syrup have been recalled after high levels of diethylene glycol were discovered in the medicine.

According to the SA Health Products Regulatory Authority (SAHPRA), diethylene glycol is a toxic compound that can be fatal if consumed.

On Saturday, SAHPRA reported that it had received a report from Nigeria's National Agency for Food and Drug Administration and Control about the detection of high levels of the substance.

The affected products have the batch numbers 329304 and 329303, and have been distributed to South Africa, Eswatini, Rwanda, Kenya, Tanzania and Nigeria.
15 Apr 2024 1PM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min